Showing results (2541-2550 of 2,668) with videos related to

Sort By:
Pageof 267
Biorxiv : the Preprint Server for Biology|May 25, 2026
Genomic signatures of selection in Anopheles funestus reveal shared and population-specific adaptive variation across African populationsHelga Modukpe Saizonou, Abdoulaye Sadio, Harouna Dit Massire Soumare, et al.
The Oncologist|February 15, 2021
The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse ReactionsCharles L Bennett, Sumimasa Nagai, Andrew C Bennett, et al.
Cell Reports|June 23, 2015
The Lipid-Modifying Enzyme SMPDL3B Negatively Regulates Innate ImmunityLeonhard X Heinz, Christoph L Baumann, Marielle S Köberlin, et al.
Journal of Human Genetics|March 22, 2025
Genetic effects on gestational diabetes mellitus and their interactions with environmental factors among Japanese womenTomoki Kawahara, Nobutoshi Nawa, Keiko Murakami, et al.
Ultrasound Quarterly|May 29, 2012
ACR Appropriateness Criteria® Multiple gestationsSandra O DeJesus Allison, Marcia C Javitt, Phyllis Glanc, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 5, 2016
Improving performance of multigene panels for genomic analysis of cancer predispositionBrian H Shirts, Silvia Casadei, Angela L Jacobson, et al.
Nature Reviews. Disease Primers|June 17, 2022
Genetic pain loss disordersAnnette Lischka, Petra Lassuthova, Arman Çakar, et al.
Nature Communications|April 14, 2018
Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagementJ M Orengo, A R Radin, V Kamat, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|July 20, 2026
Does Age Impact Relative Baseline Performance and Improvement on Clinical Speech Recognition Tests in Adult Cochlear Implant Recipients?Barak Spector, Katelyn A Berg, Michael W Canfarotta, et al.
Lancet (London, England)|September 10, 2019
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trialBruce A C Cree, Jeffrey L Bennett, Ho Jin Kim, et al.
Pageof 267